Cargando…
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Cancer poses a significant global health challenge, with predictions of increasing prevalence in the coming years due to limited prevention, late diagnosis, and inadequate success with current therapies. In addition, the high cost of new anti-cancer drugs creates barriers in meeting the medical need...
Autores principales: | Mohi-ud-din, Roohi, Chawla, Apporva, Sharma, Pooja, Mir, Prince Ahad, Potoo, Faheem Hyder, Reiner, Željko, Reiner, Ivan, Ateşşahin, Dilek Arslan, Sharifi-Rad, Javad, Mir, Reyaz Hassan, Calina, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500791/ https://www.ncbi.nlm.nih.gov/pubmed/37710280 http://dx.doi.org/10.1186/s40001-023-01275-4 |
Ejemplares similares
-
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics
por: Mir, Reyaz Hassan, et al.
Publicado: (2023) -
The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents
por: Mohi-ud-din, Roohi, et al.
Publicado: (2022) -
Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update
por: Roohi Mohi-ud-din,, et al.
Publicado: (2022) -
Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources
por: Shah, Abdul Jalil, et al.
Publicado: (2021) -
Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)